Clinical Trials Browser

Phase 1 × Lymphoma, Mantle-Cell × Ramucirumab × Clear all

NCT02745769 2019-03-05

A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents

Phase 1 Completed

GastrointestinalLymphoid

Colorectal Neoplasms, Lymphoma, Mantle-Cell